Funding Rounds
Abalos Therapeutics Series A (2019, $13M)
Abalos TherapeuticsDeveloper of new immuno-virotherapies focused on treating cancer.
Summary
Stage: Series A
Raised Amount: $13.26M
Raised Date: 2019-01-01
Stage: Series A
Raised Amount: $13.26M
Raised Date: 2019-01-01